Abstract
Nesfatin-1 is an eighty two amino acid, naturally occurring multifunctional protein encoded in the precursor nucleobindin-2 (NUCB2). A comparison of sequences indicates that NUCB2 is present in a number of animals, from hydra to humans. The 30 amino acid mid-segment of nesfatin-1 is considered to be the bioactive core of the protein, and this region displays the highest identity among nesfatin-1 sequences reported thus far. Similar to the sequence relationships observed, the tissue-specific expression and biological actions of nesfatin-1 also appear to be highly conserved across species. For example, brain is a major tissue abundantly expressing nesfatin- 1 in several species. It has been shown that various key regions of the rat, mouse and goldfish brain, which are involved in the regulation of feeding and metabolism express nesfatin-1. Exogenous administration of nesfatin-1 results in a decrease in the food intake of rats, mice and goldfish. In addition, nesfatin-1 has been shown to regulate a number of other physiological processes including hormone secretion from the pancreatic islets and pituitary gland, stress and behavior. While nesfatin-1 research still remains an emerging area in physiology, the literature available thus far clearly shows that nesfatin-1 is an important regulator of homeostasis in animals.
Keywords: Food intake, metabolism, brain, pancreas, fish, rats, mice, humans.
Current Pharmaceutical Design
Title:Phylogenetic Aspects of Nucleobindin-2/Nesfatin-1
Volume: 19 Issue: 39
Author(s): Haneesha Mohan and Suraj Unniappan
Affiliation:
Keywords: Food intake, metabolism, brain, pancreas, fish, rats, mice, humans.
Abstract: Nesfatin-1 is an eighty two amino acid, naturally occurring multifunctional protein encoded in the precursor nucleobindin-2 (NUCB2). A comparison of sequences indicates that NUCB2 is present in a number of animals, from hydra to humans. The 30 amino acid mid-segment of nesfatin-1 is considered to be the bioactive core of the protein, and this region displays the highest identity among nesfatin-1 sequences reported thus far. Similar to the sequence relationships observed, the tissue-specific expression and biological actions of nesfatin-1 also appear to be highly conserved across species. For example, brain is a major tissue abundantly expressing nesfatin- 1 in several species. It has been shown that various key regions of the rat, mouse and goldfish brain, which are involved in the regulation of feeding and metabolism express nesfatin-1. Exogenous administration of nesfatin-1 results in a decrease in the food intake of rats, mice and goldfish. In addition, nesfatin-1 has been shown to regulate a number of other physiological processes including hormone secretion from the pancreatic islets and pituitary gland, stress and behavior. While nesfatin-1 research still remains an emerging area in physiology, the literature available thus far clearly shows that nesfatin-1 is an important regulator of homeostasis in animals.
Export Options
About this article
Cite this article as:
Mohan Haneesha and Unniappan Suraj, Phylogenetic Aspects of Nucleobindin-2/Nesfatin-1, Current Pharmaceutical Design 2013; 19 (39) . https://dx.doi.org/10.2174/138161281939131127124149
DOI https://dx.doi.org/10.2174/138161281939131127124149 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk
CNS & Neurological Disorders - Drug Targets Cell-Penetrating Peptide Technology to Deliver Chaperones and Associated Factors in Diseases and Basic Research
Current Pharmaceutical Biotechnology Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases
Current Pharmaceutical Design Role of Early Growth Response-1 in the Development of Alcohol-Induced Steatosis
Current Molecular Pharmacology Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology Oxidative Stress Modulation Through Habitual Physical Activity
Current Pharmaceutical Design Diosmetin Induces Apoptosis by Downregulating AKT Phosphorylation via P53 Activation in Human Renal Carcinoma ACHN Cells
Protein & Peptide Letters Genistein: A Boon for Mitigating Ischemic Stroke
Current Topics in Medicinal Chemistry Urocortin: Cardiovascular Actions and Therapeutic Implications
Letters in Drug Design & Discovery Therapeutic Approach for Neuronal Disease by Regulating Reninangiotensin System
Current Hypertension Reviews Human Tissue Kallikrein: A New Bullet for the Treatment of Ischemia
Current Pharmaceutical Design Ca2+ Signalling in Damaged Endothelium: Do Connexin Hemichannels Aid in Filling the Gap?
Current Drug Therapy Therapeutic Potential of Targeting Protease Activated Receptors in Cardiovascular Diseases
Current Pharmaceutical Design Atrial Fibrillation in Patients Undergoing Surgical Revascularization: An Update on Pharmacologic Prophylaxis
Cardiovascular & Hematological Agents in Medicinal Chemistry Topical Antimicrobials for Burn Wound Infections
Recent Patents on Anti-Infective Drug Discovery Rationale of Hyperbaric Oxygenation in Cerebral Vascular Insult
Current Vascular Pharmacology Treatment Options in Alzheimer´s Disease: The GABA Story
Current Pharmaceutical Design Polyphenols in Disease: from Diet to Supplements
Current Pharmaceutical Biotechnology Neuromodulation of the Perinatal Respiratory Network
Current Neuropharmacology Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
Current Medicinal Chemistry